What is the share price of Zota Health Care Ltd (ZOTA) today?
The share price of ZOTA as on 9th February 2026 is ₹1328.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Zota Health Care Ltd (ZOTA) share?
The past returns of Zota Health Care Ltd (ZOTA) share are- Past 1 week: 2.98%
- Past 1 month: -8.82%
- Past 3 months: -13.46%
- Past 6 months: 10.38%
- Past 1 year: 38.23%
- Past 3 years: 318.75%
- Past 5 years: 768.58%
What are the peers or stocks similar to Zota Health Care Ltd (ZOTA)?
The peers or stocks similar to Zota Health Care Ltd (ZOTA) include:What is the dividend yield % of Zota Health Care Ltd (ZOTA) share?
The current dividend yield of Zota Health Care Ltd (ZOTA) is 0.06.What is the market cap of Zota Health Care Ltd (ZOTA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Zota Health Care Ltd (ZOTA) is ₹4524.95 Cr as of 9th February 2026.What is the 52 week high and low of Zota Health Care Ltd (ZOTA) share?
The 52-week high of Zota Health Care Ltd (ZOTA) is ₹1740 and the 52-week low is ₹752.What is the PE and PB ratio of Zota Health Care Ltd (ZOTA) stock?
The P/E (price-to-earnings) ratio of Zota Health Care Ltd (ZOTA) is -80.22. The P/B (price-to-book) ratio is 19.92.Which sector does Zota Health Care Ltd (ZOTA) belong to?
Zota Health Care Ltd (ZOTA) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Zota Health Care Ltd (ZOTA) shares?
You can directly buy Zota Health Care Ltd (ZOTA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Zota Health Care Ltd
ZOTA Share Price
1,328.503.43% (+44.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ZOTA Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ZOTA Performance & Key Metrics
ZOTA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -62.26 | 19.92 | 0.06% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.83 | 5.69 | 0.60% |
ZOTA Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ZOTA Company Profile
Zota Health Care Ltd. is a pharmaceutical company engaged in the business of manufacturing and marketing of medicines
SUNPHARMA
PE Ratio
37.42
37.42
1Y Return
1.59%
1.59%
Buy Reco %
94.44
94.44
TORNTPHARM
PE Ratio
70.78
70.78
1Y Return
25.19%
25.19%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
20.57
20.57
1Y Return
7.98%
7.98%
Buy Reco %
56.25
56.25
DRREDDY
PE Ratio
18.78
18.78
1Y Return
4.47%
4.47%
Buy Reco %
51.61
51.61
LUPIN
PE Ratio
30.59
30.59
1Y Return
1.26%
1.26%
Buy Reco %
72.22
72.22
ZOTA Forecast
ZOTA Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ZOTA
ZOTA
Income
Balance Sheet
Cash Flow
Annual Normal View
ZOTA Income Statement
ZOTA Income Statement
Annual Normal View
| Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 87.10 | 96.59 | 109.08 | 132.82 | 142.45 | 181.65 | 295.04 | 477.99 | ||||||||
Raw Materials | 64.27 | 59.57 | 75.88 | 86.67 | 99.41 | 108.83 | 180.55 | 460.46 | ||||||||
| Power & Fuel Cost | 0.54 | 0.60 | 0.70 | 0.89 | 1.27 | 2.18 | 4.21 | |||||||||
| Employee Cost | 8.02 | 9.59 | 8.58 | 9.52 | 12.19 | 29.33 | 83.69 | |||||||||
| Selling & Administrative Expenses | 10.19 | 11.80 | 21.47 | 17.25 | 34.55 | 41.47 | 66.53 | |||||||||
| Operating & Other expenses | -5.20 | 9.01 | -0.46 | 2.06 | -14.79 | -8.88 | -36.27 | |||||||||
EBITDA | 9.28 | 6.02 | 2.91 | 16.43 | 9.82 | 8.72 | -3.67 | 17.53 | ||||||||
| Depreciation/Amortization | 1.39 | 2.10 | 3.17 | 3.67 | 11.96 | 20.09 | 43.20 | 69.77 | ||||||||
| PBIT | 7.89 | 3.92 | -0.26 | 12.76 | -2.14 | -11.37 | -46.87 | -52.24 | ||||||||
| Interest & Other Items | 0.04 | 0.07 | 0.11 | 0.32 | 2.56 | 4.79 | 10.78 | 15.50 | ||||||||
| PBT | 7.85 | 3.85 | -0.37 | 12.44 | -4.70 | -16.16 | -57.65 | -67.74 | ||||||||
| Taxes & Other Items | 2.31 | 1.12 | -0.15 | 3.53 | 1.08 | -1.81 | -1.24 | 4.94 | ||||||||
| Net Income | 5.54 | 2.73 | -0.22 | 8.91 | -5.78 | -14.35 | -56.41 | -72.68 | ||||||||
| EPS | 2.26 | 1.11 | -0.09 | 3.58 | -2.30 | -5.63 | -20.71 | -25.38 | ||||||||
| DPS | 0.71 | 1.00 | 1.00 | 1.50 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||||
| Payout ratio | 0.32 | 0.90 | 0.00 | 0.42 | 0.00 | 0.00 | 0.00 | -0.04 |
ZOTA Company Updates
FY 2026FY 2026
Investor Presentation
Feb 5PDF
Nov 5PDF
Oct 19PDF
Aug 8PDF
FY 2025FY 2025
Investor Presentation
May 30PDF
Feb 13PDF
Nov 26PDF
FY 2024FY 2024
FY 2023FY 2023
Investor Presentation
Jun 26PDF
Feb 16PDF
Nov 22PDF
ZOTA Stock Peers
ZOTA Past Performance & Peer Comparison
ZOTA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Zota Health Care Ltd | -80.22 | 19.92 | 0.06% |
| Sun Pharmaceutical Industries Ltd | 37.42 | 5.64 | 0.94% |
| Torrent Pharmaceuticals Ltd | 70.78 | 17.82 | 0.80% |
| Cipla Ltd | 20.57 | 3.47 | 1.19% |
ZOTA Stock Price Comparison
Compare ZOTA with any stock or ETFCompare ZOTA with any stock or ETF
ZOTA
ZOTA Holdings
ZOTA Shareholdings
ZOTA Promoter Holdings Trend
ZOTA Promoter Holdings Trend
Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 6.78%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ZOTA Institutional Holdings Trend
ZOTA Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has increased by 4.60%
ZOTA Shareholding Pattern
ZOTA Shareholding Pattern
ZOTA Shareholding History
ZOTA Shareholding History
Foreign Institutions
Mutual Funds Invested in ZOTA
Mutual Funds Invested in ZOTA
No mutual funds holding trends are available
Top 2 Mutual Funds holding Zota Health Care Ltd
| Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.3403% | Percentage of the fund’s portfolio invested in the stock 1.07% | Change in the portfolio weight of the stock over the last 3 months 1.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 87/119 (+26) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1554% | Percentage of the fund’s portfolio invested in the stock 1.34% | Change in the portfolio weight of the stock over the last 3 months 0.77% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 45/74 (0) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ZOTA stock
smallcases containing ZOTA stock
Looks like this stock is not in any smallcase yet.
ZOTA Events
ZOTA Events
ZOTA Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ZOTA has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.07%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.65 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ZOTA Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ZOTA has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.07%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.65 every year
ZOTA Upcoming Dividends
ZOTA Upcoming Dividends
No upcoming dividends are available
ZOTA Past Dividends
ZOTA Past Dividends
Cash Dividend
Ex DateEx DateSep 22, 2025
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 22, 2025
Cash Dividend
Ex DateEx DateSep 20, 2024
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 20, 2024
Cash Dividend
Ex DateEx DateSep 22, 2023
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 22, 2023
Cash Dividend
Ex DateEx DateSep 19, 2022
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 19, 2022
Cash Dividend
Ex DateEx DateSep 22, 2021
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 22, 2021
ZOTA Stock News & Opinions
ZOTA Stock News & Opinions
Articles & Videos
Earnings
Zota Health Care reports consolidated net loss of Rs 29.50 crore in the December 2025 quarter
Net Loss of Zota Health Care reported to Rs 29.50 crore in the quarter ended December 2025 as against net loss of Rs 18.68 crore during the previous quarter ended December 2024. Sales rose 98.21% to Rs 142.95 crore in the quarter ended December 2025 as against Rs 72.12 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales142.9572.12 98 OPM %-0.31-8.42 - PBDT-3.70-7.14 48 PBT-25.95-18.48 -40 NP-29.50-18.68 -58 Powered by Capital Market - Live
4 days agoCapital Market - Live
Corporate
Zota Health Care to convene board meeting
Zota Health Care will hold a meeting of the Board of Directors of the Company on 4 February 2026.Powered by Capital Market - Live
1 week agoCapital Market - Live
Spotlight
Zota Health Care gains after adding 276 Davaindia Stores in Q3 FY26
The company's COCO segment opened 231 stores in Q3 FY26, taking the total number of COCO stores managed by wholly owned subsidiary Davaindia Health Mart to 1,207 as of 30 September 2025. The FOFO segment added 45 stores during the quarter, bringing its total to 848 stores as of 30 September 2025. Zota Health Care is engaged in the manufacturing and marketing of pharmaceutical products, serving both domestic and international markets. The company reported a 31.8% decline in consolidated net profit to Rs 15.95 crore in Q2 FY26, despite a 91.7% surge in total revenue to Rs 128.95 crore compared with Q2 FY25. Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Zota Health Care reports consolidated net loss of Rs 15.95 crore in the September 2025 quarter
Net Loss of Zota Health Care reported to Rs 15.95 crore in the quarter ended September 2025 as against net loss of Rs 12.10 crore during the previous quarter ended September 2024. Sales rose 91.66% to Rs 128.95 crore in the quarter ended September 2025 as against Rs 67.28 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales128.9567.28 92 OPM %4.90-1.29 - PBDT4.13-3.18 LP PBT-14.38-12.69 -13 NP-15.95-12.10 -32 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Zota Health Care to hold board meeting
Zota Health Care will hold a meeting of the Board of Directors of the Company on 17 October 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Zota Health Care AGM scheduled
Zota Health Care announced that the 25th Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Zota Health Care to hold board meeting
Zota Health Care will hold a meeting of the Board of Directors of the Company on 4 September 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Zota Health Care reports consolidated net loss of Rs 14.32 crore in the June 2025 quarter
Net Loss of Zota Health Care reported to Rs 14.32 crore in the quarter ended June 2025 as against net loss of Rs 12.72 crore during the previous quarter ended June 2024. Sales rose 83.98% to Rs 103.58 crore in the quarter ended June 2025 as against Rs 56.30 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales103.5856.30 84 OPM %3.81-2.24 - PBDT1.59-4.14 LP PBT-13.08-12.16 -8 NP-14.32-12.72 -13 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Zota Health Care to discuss results
Zota Health Care will hold a meeting of the Board of Directors of the Company on 8 August 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Zota Health Care reports consolidated net loss of Rs 12.89 crore in the March 2025 quarter
Net Loss of Zota Health Care reported to Rs 12.89 crore in the quarter ended March 2025 as against net loss of Rs 6.92 crore during the previous quarter ended March 2024. Sales rose 95.95% to Rs 97.27 crore in the quarter ended March 2025 as against Rs 49.64 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 56.40 crore in the year ended March 2025 as against net loss of Rs 14.35 crore during the previous year ended March 2024. Sales rose 62.32% to Rs 292.97 crore in the year ended March 2025 as against Rs 180.49 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales97.2749.64 96 292.97180.49 62 OPM %2.54-3.00 --1.964.18 - PBDT0.01-2.71 LP -14.453.92 PL PBT-14.30-9.51 -50 -57.64-16.16 -257 NP-12.89-6.92 -86 -56.40-14.35 -293 Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 25.02%, vs industry avg of 10.04%
Over the last 5 years, market share increased from 0.04% to 0.07%